Champions Oncology, Inc. (NASDAQ:CSBR) | WebDisclosure

Basculer en Français

10118	Companies
207460	Keywords
137569	Articles
109945	Press releases

Headlines Articles Press releases Champions Oncology, Inc.

Home
Companies
Champions Oncology, Inc.

BRIEF

published on 03/30/2026 at 17:00, 4 hours 36 minutes ago

Champions Oncology Appoints Brian Alexander to Board, Highlights Data-Focused Strategy

Data Strategy Champions Oncology Brian Alexander Oncology R&D Tumor Models
BRIEF

published on 03/30/2026 at 17:00, 4 hours 36 minutes ago

Champions Oncology nomme Brian Alexander à son conseil d'administration et met en avant sa stratégie axée sur les données

Stratégie De Données Champions Oncology Brian Alexander Recherche Et Développement En Oncologie Modèles De Tumeurs
PRESS RELEASE

published on 03/30/2026 at 16:55, 4 hours 41 minutes ago

Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
Champions Oncology appoints Dr. Brian Alexander to its Board of Directors, enhancing its focus on leveraging clinically relevant data for oncology R&D. The appointment strengthens the company's strategy of using data to drive drug discovery and development

Champions Oncology Brian Alexander Oncology R&D Clinically Relevant Data Translational Research
BRIEF

published on 07/08/2025 at 14:35, 8 months 22 days ago

Champions Oncology Launches Comprehensive Radiopharmaceutical Platform

PDX Models Radioligand Therapy Oncology Drug Development Radiopharmaceutical Services Isotope License
BRIEF

published on 07/08/2025 at 14:35, 8 months 22 days ago

Champions Oncology lance une plateforme radiopharmaceutique complète

Modèles PDX Thérapie Par Radioligand Développement De Médicaments Oncologiques Services Radiopharmaceutiques Licence D'isotope
PRESS RELEASE

published on 07/08/2025 at 14:30, 8 months 22 days ago

Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models
Champions Oncology announces the full commercial launch of its radiopharmaceutical services platform, offering integrated radiopharmaceutical studies with clinically relevant isotopes and PDX tumor models

Oncology Research Radiopharmaceuticals Champions Oncology PDX Tumor Models Radioactive Isotopes
BRIEF

published on 04/28/2025 at 15:50, 11 months 2 days ago

Champions Oncology Secures Radioactive Materials License for Radiotherapeutic Research

PDX Models Radiotherapeutics Champions Oncology Radioactive Materials Translational Oncology
BRIEF

published on 04/28/2025 at 15:50, 11 months 2 days ago

Champions Oncology obtient une licence de matériaux radioactifs pour la recherche radiothérapeutique

Modèles PDX Radiothérapie Champions Oncologie Matières Radioactives Oncologie Translationnelle
PRESS RELEASE

published on 04/28/2025 at 15:45, 11 months 2 days ago

Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House
Champions Oncology granted license for radioactive materials in preclinical studies, enhancing capabilities in radiotherapeutics development. CEO Ronnie Morris highlights the importance of this milestone

Preclinical Studies Radiotherapeutics Champions Oncology Radioactive Materials Biopharmaceutical Partners
BRIEF

published on 01/08/2025 at 14:05, 1 year 2 months ago

Champions Oncology Expands Bioanalytical Services with New Technology

Oncology Research Champions Oncology Bioanalytical Services Cytek Aurora Troy Tremaine

Accesswire

Published on 03/30/2026 at 20:45, 51 minutes ago

Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/30/2026 at 16:55, 4 hours 41 minutes ago

Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
Published on 03/30/2026 at 16:25, 5 hours 11 minutes ago

CORRECTION: Mandela Dollar ("MUSD") Announced to Promote Mandela's Legacy of Financial Inclusion for Underserved Communities Across the World
Published on 03/30/2026 at 15:15, 6 hours 21 minutes ago

Mandela Dollar ("MUSD") Announced to Promote Mandela's Legacy of Financial Inclusion for Underserved Communities Across the World
Published on 03/30/2026 at 14:30, 7 hours 6 minutes ago

Namibia Critical Metals and JOGMEC Amend Agreement to Increase Earn-In Funding for the Lofdal Heavy Rare Earths Project

View all ACCESSWIRE

EQS Group

Published on 03/30/2026 at 20:40, 55 minutes ago

Orderfox Schweiz AG Introduces Gieni ABX in collaboration with Microsoft: A Frontier AI Solution That Executes Work to Completion
Published on 03/30/2026 at 19:20, 2 hours 16 minutes ago

Basler publishes audited 2025 financial statements, including a forecast for 2026, and approves a dividend resolution
Published on 03/30/2026 at 19:00, 2 hours 36 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 23 MARS 2026 au 27 MARS 2026
Published on 03/30/2026 at 18:28, 3 hours 7 minutes ago

AEVIS VICTORIA SA (AEVS) - Infracore SA - See-Spital renforce ses bases financières grâce à un partenariat à long terme avec Infracore SA pour ses infrastructures
Published on 03/30/2026 at 18:28, 3 hours 7 minutes ago

AEVIS VICTORIA SA (AEVS) - Infracore SA - See-Spital strengthens its financial foundation through a long-term infrastructure partnership with Infracore

Les Echos

Published on 03/30/2026 at 18:45, 2 hours 51 minutes ago

ENGIE is expanding its power transmission activities in Brazil with the award of new concessions
Published on 03/30/2026 at 18:45, 2 hours 51 minutes ago

ENGIE se renforce dans le transport d'électricité au Brésil grâce au gain de nouvelles concessions
Published on 03/30/2026 at 18:45, 2 hours 51 minutes ago

ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/30/2026 at 18:42, 2 hours 53 minutes ago

Résultat annuel 2025
Published on 03/30/2026 at 18:22, 3 hours 13 minutes ago

Résultat annuel 2025

View all LES ECHOS COMFI WIRE